MYAMBUTOL

This brand name is authorized in United States. It is also authorized in Austria, France, Malta, Netherlands, Spain.

Active ingredients

The drug MYAMBUTOL contains one active pharmaceutical ingredient (API):

1	Ethambutol UNII QE4VW5FO07 - ETHAMBUTOL HYDROCHLORIDE
	Ethambutol is bacteriostatic. It is effective against Mycobacterium tuberculosi and M.bovis with an MIC of 0.5–8µg per ml. The exact mechanism of action is unknown. While it has activity against some atypical mycobacteria including M.Kansasii, activity against other micro-organisms has not yet been reported.
	Read more about Ethambutol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYAMBUTOL Film-coated tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J04AK02	Ethambutol	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AK Other drugs for treatment of tuberculosis
Discover more medicines within J04AK02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	44430
FR	Base de données publique des médicaments	60074934, 69861990
MT	Medicines Authority	AA565/22804
NL	Z-Index G-Standaard, PRK	6343
US	FDA, National Drug Code	68850-010, 68850-012, 70518-2691